Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

99-MiDeTe

ABSTRACT: 99-MiDeTe

PROVIDER: PRJNA851356 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19761971.fastq.gz	Fastqsanger.gz
	SRR19761972.fastq.gz	Fastqsanger.gz
	SRR19761973.fastq.gz	Fastqsanger.gz
	SRR19761974.fastq.gz	Fastqsanger.gz
	SRR19761975.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Acidovorax sp. 99 strain:99

Project description:Acidovorax sp. 99 strain:99 Genome sequencing and assembly

| PRJNA442015 | ENA

Hyphomicrobium sp. 99 strain:99

Project description:Hyphomicrobium sp. 99

| PRJNA185289 | ENA

Acidovorax sp. 99 strain:99

Project description:Acidovorax sp. 99 transcriptome - Chisto_RNA_34

| PRJNA566720 | ENA

Sinorhizobium medicae strain:99

Project description:Sinorhizobium medicae 99 Resequencing

| PRJNA501590 | ENA

Bradyrhizobium elkanii strain:USDA 99 | isolate:USDA 99

Project description:Bradyrhizobium elkanii USDA 99 genome sequencing

| PRJNA834279 | ENA

miR-99 overexpression modulates neutrophil migration

Project description:We performed RNAseq to identify miRNAs that were specifically down regulated in neutrophils, and RNAseq for identification of mRNA targets of miRNA-99 in neutrophils

2021-02-06 | GSE144873 | GEO

RNA-sequencing of stably engrafted miR-99 KD LSKs

Project description:We FACS-purified GFP+ LSK cells from mice transplanted with stably engrafted miR-99 KD and Scr HSCs and performed RNA-sequencing, demonstrating miR-99 KD results in significant depletion of hematopoietic stem cell gene expression signature and induces a differentiated progenitor gene expression signature.

2017-07-27 | GSE101903 | GEO

miRNA-99 family diverges physiological cardiac hypertrophy to pathological cardiac hypertrophy

Project description:Purpose: The physiological cardiac hypertrophy is an adaptive condition that does not associate with myocyte cell death while pathological hypertrophy is a maladaptive condition associated with myocyte cell death. Alpha-2 macroglobulin (α-2M) an acute phase protein induces cardiac hypertrophy via the ERK1,2 and PI3K/Akt signaling. This study is aimed at exploring the miRNome of α-2M induced hypertrophied cardiomyocytes and to understand the role of miRNAs in determination of pathological and physiological hypertrophy. Methods: Hypertrophy was induced in H9c2 cardiomyoblasts using alpha-2 macroglobulin. The induction of hypertrophy is confirmed by microscopy and gene expression studies. Subsequently, the total RNA was isolated and small RNA sequencing was executed in Illumina HiSeq 2000. Results: Analysis of small RNA reads revealed the differential expression of a large set of miRNAs during hypertrophy. Among the differentially expressed candidates, miR-99 family (miR-99a, miR-99b and miR-100) showed significant downregulation upon α-2M treatment while isoproterenol treatment (pathological hypertrophy) upregulated their expression. The binding site for Egr1 transcription factor was identified in the promoter region of miR-99 family, and interestingly all miRNAs with Egr1 binding site proven by ChIP-Seq were downregulated during physiological hypertrophy Conclusions: The results proved Egr-1 mediated regulation of miR-99 family determines the uniqueness of pathological and physiological hypertrophy. Upregulated miR-99 expression during pathological hypertrophy suggests that it can be a valuable diagnostic marker and potential therapeutic target for cardiac hypertrophy and heart failure.

2015-11-01 | GSE73597 | GEO

Pseudomonas sp. 99-1621

Project description:Pseudomonas sp. 99-1621 Genome sequencing

| PRJNA244520 | ENA

Marinobacter sp. MBR-99

Project description:Marinobacter sp. MBR-99 Genome sequencing

| PRJNA1115681 | ENA